- Home
- BP vs BDX Comparison
BP vs BDX Comparison
Compare BP & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BP
- BDX
- Stock Information
- Founded
- BP 1889
- BDX 1897
- Country
- BP United Kingdom
- BDX United States
- Employees
- BP N/A
- BDX N/A
- Industry
- BP Integrated oil Companies
- BDX Medical/Dental Instruments
- Sector
- BP Energy
- BDX Health Care
- Exchange
- BP Nasdaq
- BDX Nasdaq
- Market Cap
- BP 75.7B
- BDX 66.1B
- IPO Year
- BP N/A
- BDX 1962
- Fundamental
- Price
- BP $31.09
- BDX $235.78
- Analyst Decision
- BP Hold
- BDX Strong Buy
- Analyst Count
- BP 10
- BDX 6
- Target Price
- BP $36.35
- BDX $283.50
- AVG Volume (30 Days)
- BP 8.7M
- BDX 2.1M
- Earning Date
- BP 02-04-2025
- BDX 02-06-2025
- Dividend Yield
- BP 6.17%
- BDX 1.77%
- EPS Growth
- BP N/A
- BDX 18.61
- EPS
- BP 0.16
- BDX 5.86
- Revenue
- BP $193,929,000,000.00
- BDX $20,178,000,000.00
- Revenue This Year
- BP N/A
- BDX $10.12
- Revenue Next Year
- BP N/A
- BDX $5.02
- P/E Ratio
- BP $30.47
- BDX $40.24
- Revenue Growth
- BP N/A
- BDX 4.16
- 52 Week Low
- BP $27.82
- BDX $218.75
- 52 Week High
- BP $40.40
- BDX $248.42
- Technical
- Relative Strength Index (RSI)
- BP 61.84
- BDX 66.28
- Support Level
- BP $30.88
- BDX $231.36
- Resistance Level
- BP $31.96
- BDX $238.11
- Average True Range (ATR)
- BP 0.47
- BDX 3.99
- MACD
- BP 0.22
- BDX 1.11
- Stochastic Oscillator
- BP 75.90
- BDX 83.26
About BP BP p.l.c.
BP is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2023, it produced 1.1 million barrels of liquids and 6.9 billion cubic feet of natural gas per day. At the end of 2023, reserves stood at 6.8 billion barrels of oil equivalent, 55% of which are liquids. The company operates refineries with a capacity of 1.6 million barrels of oil per day.
About BDX Becton Dickinson and Company
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.